Mass treatment for trachoma: how does it all work?

The World Health Organization (WHO) initiated a global programme to eliminate trachoma by 2020. At its core is the SAFE strategy: Surgery, Antibiotics, Facial cleanliness and Environmental improvement to reduce transmission. Trachoma control efforts have increased with mass drug administration (MDA)...

Full description

Saved in:
Bibliographic Details
Published inCommunity eye health Vol. 26; no. 82; pp. 38 - 39
Main Author Rono, Hillary K
Format Journal Article
LanguageEnglish
Published England International Centre for Eye Health 2013
International Centre for Eye Health (ICEH), London
Subjects
Community participation
Eye medicines
Planning and management
Primary health care
SAFE strategy
Trachoma
Trachoma Update Series
Volunteers
Online AccessGet full text

Cover

More Information
Summary:The World Health Organization (WHO) initiated a global programme to eliminate trachoma by 2020. At its core is the SAFE strategy: Surgery, Antibiotics, Facial cleanliness and Environmental improvement to reduce transmission. Trachoma control efforts have increased with mass drug administration (MDA) of azithromycin (Zithromax), an antibiotic donated by Pfizer Inc. The goal is 80% coverage in endemic areas for at least 3 years.To maximise coverage, programme managers and health workers must understand the community’s knowledge and health priorities as well as their attitudes and beliefs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0953-6833
1993-7288